Submission Details
| 510(k) Number | K231927 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 30, 2023 |
| Decision Date | March 22, 2024 |
| Days to Decision | 266 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K231927 is an FDA 510(k) clearance for the Elecsys PTH , Elecsys PTH STAT, a Radioimmunoassay, Parathyroid Hormone (Class II — Special Controls, product code CEW), submitted by Roche Diagnostics (Indianapolis, US). The FDA issued a Cleared decision on March 22, 2024, 266 days after receiving the submission on June 30, 2023. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1545.
| 510(k) Number | K231927 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 30, 2023 |
| Decision Date | March 22, 2024 |
| Days to Decision | 266 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | CEW — Radioimmunoassay, Parathyroid Hormone |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1545 |